We are thrilled and honored to announce a significant milestone for Frontiers Health 2023. On November 10th, we will host the inaugural Digital Medicine & DTx Global Policy Summit, organized by Healthware Group and the Digital Therapeutics Alliance, in collaboration with APACMed.
This summit promises to be an essential event for industry leaders and ecosystem stakeholders, addressing critical issues and driving the discourse on scaling access and adoption of digital medicines and digital therapeutics.
Alberta Spreafico, Co-leading the Summit and Healthware’s Digital Health & Innovation Managing Director, anticipates –
The DM&DTx Global Policy Summit will bring together subject matter experts, policy makers and industry leaders from Europe, the United States and the APAC region to share country- specific developments, foster cross-country exchange of best practices and explore areas of potential harmonization to help scale equitable access, systemic adoption and value generation of evidence-based software as medical devices.
Andy Molnar, CEO of the Digital Therapeutics Alliance and Emilie Lopes-Fernandes, DTA Program Lead, also share how –
This summit will serve as the premier forum for stakeholders across the digital therapeutics ecosystem to align on best practices and lessons learned for regulating and reimbursing these innovative products. By sharing key insights from recent pivotal reports, collaborating to address obstacles, and capitalizing on current momentum, participants can help pave the way for faster DTx adoption and access.
Roberto Ascione, Chairman of Frontiers Health and CEO of Healthware Group, shares how –
This summit represents a milestone in our evolving journey as a global community of health innovators – from imagining the potential of evidence-based therapeutic interventions driven by software to helping them scale in terms of adoption and impact.
Frontiers Health has consistently highlighted the potential of evidence-based therapeutic interventions driven by software programs for the treatment of diseases. As the landscape continues to mature, we remain acutely aware of the ongoing challenges related to generating real-world evidence, navigating reimbursement processes, establishing regulatory frameworks, and implementing these innovations in clinical practice.
Looking back to 2017, when we hosted the first European unveiling of the Digital Therapeutics Alliance, we can reflect on the achievements, setbacks, and remarkable leaps that have since occurred in the industry. Over the course of multiple conference editions, catalysed by our global co-host, Healthware Group, our platform has cultivated and reinforced strategic partnerships aimed at promoting and elucidating opportunities in the fields of Digital Therapeutics and digital medicine. We couldn’t be more excited to host the Summit as it will be instrumental in thriving the health innovation space.
Discover more about the sessions and the confirmed speakers here and keep an eye out for additional updates and details.
Get your FH23 pass and don’t miss out on the chance to join the 2023 Digital Medicine & DTx Global Policy Summit!
